Dyfyniad APA

Seystahl, K., Hentschel, B., Loew, S., Gramatzki, D., Felsberg, J., Herrlinger, U., . . . Weller, M. (2019). P14.108 Bevacizumab versus alkylating chemotherapy in recurrent glioblastoma. Neuro Oncol.

Dyfyniad Arddull Chicago

Seystahl, K., et al. "P14.108 Bevacizumab Versus Alkylating Chemotherapy in Recurrent Glioblastoma." Neuro Oncol 2019.

Dyfyniad MLA

Seystahl, K., et al. "P14.108 Bevacizumab Versus Alkylating Chemotherapy in Recurrent Glioblastoma." Neuro Oncol 2019.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.